ClinConnect ClinConnect Logo
Search / Trial NCT05977049

Psychosocial Support for Patients With Takotsubo Syndrome

Launched by WEILL MEDICAL COLLEGE OF CORNELL UNIVERSITY · Jul 27, 2023

Trial Information

Current as of July 26, 2025

Recruiting

Keywords

Takotsubo Cardiomyopathy Takotsubo Syndrome

ClinConnect Summary

This clinical trial is studying whether joining a virtual support group can help patients with Takotsubo Syndrome feel less anxious over the course of a year. Takotsubo Syndrome, sometimes called "broken heart syndrome," is a condition that can cause temporary heart muscle problems, often triggered by stressful events. The researchers believe that connecting with others who are going through similar experiences can improve mental well-being.

To participate in this study, you need to be at least 18 years old and have a confirmed diagnosis of Takotsubo Syndrome. However, if you are already receiving therapy for emotional support or belong to certain groups, like pregnant women or non-English speakers, you won’t be eligible to join. If you take part, you can expect to engage in online meetings with other patients, share experiences, and receive support to help manage anxiety. The goal is to see if this type of support can make a positive difference in your emotional health over time.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - All patients with documented diagnosis of Takotsubo Syndrome greater than 18 years old.
  • Exclusion Criteria:
  • Patients with a diagnosis of Takotsubo Syndrome already undergoing Psychotherapy or those who choose not to participate.
  • Vulnerable populations such as prisoners, non-English speaking subjects, pregnant women, and subjects unable to provide written informed consent will not be included in this research.

About Weill Medical College Of Cornell University

Weill Medical College of Cornell University is a leading academic institution dedicated to advancing medical research and education. As a prominent sponsor of clinical trials, it focuses on innovative healthcare solutions and the development of new therapies across various medical disciplines. The institution is committed to fostering collaborative research efforts that enhance patient care and improve health outcomes. With a robust infrastructure and a team of experienced researchers and clinicians, Weill Cornell aims to translate scientific discoveries into practical applications, ensuring a strong emphasis on ethical standards and regulatory compliance throughout the clinical trial process.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Jim Cheung, MD

Principal Investigator

Weill Medical College of Cornell University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported